Messages by Thread
-
Re: [CML] 76 Days Post BMT----First Setback
myvety2k
-
[CML] Zavie??
Ana
-
[CML] Pic Of The Day | April 25, 2005
Rob
-
[CML] Antioxidant-Rich Foods Curb Stroke Damage
[email protected]
-
[CML] DNA Damage In Cancer Sooner Than Thought
[email protected]
-
[CML] New Celebrity Dx w/CML
bheathcote201
-
[CML] Sexual dysfunction in males with chronic hepatitis C and antiviral therapy
[email protected]
-
[CML] Dane's Digital Moments 4/24
Dane
-
[CML] Molecular and Functional Characterization of NKG2D, NKp80, and NKG2C Triggering NK Cell Receptors in Rhesus and Cynomolgus Macaques: Monitoring of NK Cell Function during Simian HIV Infection
Rob
-
[CML] Cyclooxygenase-2 induction and prostaglandin E2 accumulation in squamous cell carcinoma as a consequence of epidermal growth factor receptor activation by imatinib mesylate
Rob
-
[CML] Nonaqueous capillary electrophoresis method for the analysis of gleevec and its main metabolite in human urine
Rob
-
[CML] Cost-Efficacy of Imatinib versus Allogeneic Bone Marrow Transplantation with a Matched Unrelated Donor in the Treatment of Chronic Myelogenous Leukemia: A Decision-Analytic Approach
Rob
-
[CML] Kentucky Derby Festival
Rob
-
[CML] Bone marrow changes in chronic myelogenous leukaemia after long-term treatment with the tyrosine kinase inhibitor STI571
Rob
-
[CML] Concurrent medications with Gleevec
Rob
-
[CML] Medicare Change Will Limit Access to Claim Hearings
[email protected]
-
[CML] Pain in legs, Help!
eagledove605
-
[CML] Spofford girl's transplant set for June 17
Rob
-
[CML] Pic Of The Day | April 23, 2005
Rob
-
[CML] PCR Test
micaelahase
-
[CML] Dane's Digital Moments 4/22
Dane
-
[CML] Pic Of The Day | April 22, 2005
Rob
-
[CML] BCR-ABL induces the expression of Skp2 through the PI3K pathway to promote p27Kip1 degradation and proliferation of chronic myelogenous leukemia cells
Rob
-
[CML] A basic classification and a comprehensive examination of pediatric myeloproliferative syndromes
Rob
-
[CML] Proteome analysis of nuclear matrix proteins during arsenic trioxide induced apoptosis in K562 cells
Rob
-
[CML] Imatinib (STI571) induces DNA damage in BCR/ABL-expressing leukemic cells but not in normal lymphocytes
Rob
-
[CML] After imatinib: new hopes for chronic myeloid leukaemia
Rob
-
[CML] Gateways to clinical trials
Rob
-
Re: [CML] BMT Plus 72 Update/Dane DANE HI THERE
Lynda Niemczyk
-
[CML] BMT Plus 72 Update/Dane
Dane
-
[CML] My Email Is Off
Rob
-
Re: [CML] Digest Number 3968
IAintFinishedYet
-
[CML] British Medical Journal Takes On Big Pharma
Rob
-
[CML] Pic Of The Day | April 21, 2005
Rob
-
[CML] A Ride for the Cure of Leukemia
Margot M
-
[CML] PRAECIS PHARMACEUTICALS INCORPORATED Provides Update on Direct Select Technology at Molecular Medicine Tri-Conference
Rob
-
[CML] New Leukemia Drug Overcomes Gleevec Resistance
Rob
-
[CML] New era drug gives hope to Gleevec resistant leukaemia sufferers
Rob
-
[CML] Pic Of The Day | April 20, 2005
Rob
-
[CML] Heads Up! This is important news
Cheryl-Anne Simoneau
-
Re: [CML] Digest Number 3967
Libby Scrivner
-
[CML] broken ribs
Ana
-
[CML] Next-era targeted therapy overcoming Gleevec's shortcomings
Rob
-
[CML] CML found to wield 'death factor' that kills normal blood marrow cells
Rob
-
[CML] BCR ABL TEST
jiggysgirl2003
-
[CML] Pic Of The Day | April 19, 2005
Rob
-
[CML] Dane's Digital Moments 4/18
Dane
-
[CML] double diagnosis
carolannkalat
-
Re: [CML] Lynn F.
MoonQn1
-
[CML] HELP anyone have to go to novartis for help getting gleevec?????????/
judy
-
[CML] Pic Of The Day | April 18, 2005
Rob
-
[CML] Aiding son is a labor of love for executive
Rob
-
[CML] Dane's Digital Moments 4/17
Dane
-
[CML] Pic Of The Day | April 17, 2005
Rob
-
[CML] The t(8;21) translocation converts AML1 into a constitutive transcriptional represso
Rob
-
[CML] Bilateral recurrent calcareous degeneration of the cornea
Rob
-
[CML] Regulatory role of HTm4 gene in hematopoietic cell cycle
Rob
-
[CML] Role of cytochrome p450 activity in the fate of anticancer agents and in drug resistance : focus on tamoxifen, Paclitaxel and imatinib metabolism
Rob
-
[CML] Survival benefit with imatinib mesylate therapy in patients with accelerated-phase chronic myelogenous leukemia-Comparison with historic experience.
Rob
-
[CML] Regatta incorporates large sailboats and Duffy boats to benefit cancer research
Rob
-
[CML] Gleevec vs. Liver
IAintFinishedYet
-
[CML] Clinical Trials From Centerwatch
Rob
-
[CML] Combat Stress by Creating Your Own Oasis
Rob
-
[CML] Pic Of The Day | April 16, 2005
Rob
-
[CML] Dane's Digi-Moments 4/15
Dane
-
[CML] Pic Of The Day | April 15, 2005
Rob
-
[CML] Influenza B virus pneumonia after bone marrow transplantation: case report with emphasis to the high resolution computed tomography findings
Rob
-
[CML] Chronic myelogenous leukemia manifested as bilateral proliferative retinopathy.
Rob
-
[CML] RE: Darvocet
Lisa Martinez
-
[CML] For Lynne
Bob Stewart
-
[CML] bob and lynne/ Darvoset
MJHodor
-
[CML] Darvoset
Bob Stewart
-
[CML] Dane's Digi-Moments 4/14
Dane
-
[CML] Seattle Genetics In-licenses Anti-CD33 Antibody Program from Protein Design Labs
[email protected]
-
[CML] Pic Of The Day | April 14, 2005
Rob
-
[CML] BMT + 64 and still doing fine.
Dane
-
[CML] Pic Of The Day | April 13, 2005
Rob
-
[CML] Gene expression analysis fails to identify patients with chronic myeloid leukemia who will achieve cytogenetic response to imatinib
Rob
-
[CML] In chronic myeloid leukemia white cells from cytogenetic responders and non-responders to imatinib have very similar gene expression signatures
Rob
-
[CML] New tyrosine kinase inhibitors in chronic myeloid leukemia
Rob
-
[CML] Clonal cytogenetic abnormalities in patients with chronic myeloid leukemia in complete cytogenetic response to imatinib mesylate
Rob
-
[CML] Sailor needs bone marrow match to survive leukemia
Rob
-
Re: [CML] RE: Help?
Daman Batra
-
[CML] Fluorescence In Situ Hybridization Monitoring of BCR-ABL-Positive Neutrophils in Chronic-Phase Chronic Myeloid Leukemia Patients during the Primary Stage of Imatinib Mesylate Therapy
Rob
-
[CML] Pic Of The Day | April 12, 2005
Rob
-
[CML] Another Mayfield Sighting.
Dane
-
[CML] RE: Disposal of leftover Gleevec???
Lisa Martinez
-
[CML] Disposal of leftover Gleevec???
debra moretz
-
[CML] Use of arsenic trioxide in haematological malignancies: insight into the clinical development of a novel agent
Rob
-
[CML] Successful Treatment with Imatinib Mesylate in a Case of Minor BCR-ABL-Positive Acute Myelogenous Leukemia
Rob
-
[CML] Nonproliferating CML CD34(+) progenitors are resistant to apoptosis induced by a wide range of proapoptotic stimuli
Rob
-
[CML] On the Molecular Origins of the Chronic Myeloproliferative Disorders: It All Makes Sense
Rob
-
[CML] Role of poly(ADP-ribose) polymerase activity in imatinib mesylate-induced cell death
Rob
-
[CML] Dane's Digital Moments 4/10
Dane
-
[CML] Temple University Researchers Develop New Targeted Cancer Therapy
Rob
-
[CML] Re: [CMLHope] cml & bones
Rob
-
[CML] cml & bones
Ana
-
[CML] File - Organizers Needed For CML Local Support Group Meetings
CML
-
[CML] File - Participation In The Group Is Requested
CML
-
[CML] Pic Of The Day | April 10, 2005
Rob
-
Re: [CML] Digest Number 3956
IAintFinishedYet
-
[CML] Still seeking help with a study to improve online cancer information
dr_beaudoin
-
[CML] Pic Of The Day | April 09, 2005
Rob
-
[CML] Detecting a Cure
Rob
-
[CML] Re: Stem Cell Legislation
Cynthia Schaefer
-
[CML] Reminder - Join Both Our Yahoo And Google Groups
CML